to yield anti-Ia.22 and anti-Ia.23 antibodies after multiple immunizations. In this study we present serological and biochemical evidence that Ia.22 and Ia.23 are present on hybrid Ia molecules from F1 animals but not expressed in either parent.
Materials and Methods
Animals. All mice used in these studies were produced and maintained in our Immunogenetics mouse colony (Mayo Clinic, Rochester, Minn.). We used (BI0 × B 10.D2)FI animals for the detection of specificity Ia.22 and [D2.GD × B10.A(5R)]FI animals for the detection of Ia.23. H-2 haplotypes of recombinant strains used in this study are noted in Table I .
Antisera. The antisera were produced in our laboratory as previously described (11) . To detect Ia.22, the antiserum (C3H.Q X B10.D2)F1 anti-B10•AQR was used in most of these studies. This antiserum, besides anti-Ia.22 activity, also contains activity against the I-A ~ subregion. However, it is negative with both the parental haplotypes, B10 (H-2 b) and B10.D2 (H-2 a) from which the F1 was produced. Specificity and mapping of Ia.22 is defined by the LG X C3H/Hej)F1 anti-C3H.OL. This antiserum is specific for Ia.23. Even though this recipient-donor combination has incompatibility for the I-A subregion, it has no activity against the I-A a-coded antigens. The antiserum is negative on both the parental strains, D2.GD and B10.A(5R), used to produce the F1 animals. As an added cautionary measure the anti-Ia.22 was absorbed with B10.A(4R) (I-A k) to make it specific for Ia.22, and anti-Ia.23 was absorbed with D2•GD (I-A a) to make it specific for Ia.23, The following antisera were also C)totoxic Tests. Serological tests for the detection of hybrid Ia antigens were done by a microcytotoxic dye-exclusion assay as previously described (12) . The target cells were either fresh spleen cells or 72-h cultures of lipopolysaccharide (LPS)-stimulated spleen blasts. LPS blasts were prepared as previously described (13) . In vitro absorptions were performed by incubating 250/11 of 1:10 dilution of the antisera with 100 million fresh spleen cells or LPS spleen blasts for 1 h.
Immunopreczpitation and Sodium Dodecyl Sulfate (SDS) Gel Electrophoresis.
Fl and parental LPSstimulated blast cells were prepared by culturing 48-h LPS spleen cells in RPMI-1640 media (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 50 #g/ml LPS as previously described (13) . The LPS-stimulated blast cells were radiolabeled in RPMI-1640 media without leucine supplemented with glutamine, penicillin (100 U), streptomycin (100 U), 5% fetal calf serum, and 30 #Ci/ml [:3H]leucine. The LPS blasts were radiolabeled at 37°C in a 5% CO2 incubator for 12 h. The radiolabeled cells were then solubilized with 0.50~7~ Triton X-100 (Rohm and Haas, Philadelphia, Pa.) in Tris-buffered saline, centrifuged, and the extract was then purified by lentil lectin affinity chromatography. The lentil lectin-purified extracts were tested with anti-Ia.22 and anti-Ia.23 sera with standard immunoprecipitation and SDSpolyacrylamide gel electrophoresis procedures previously described (14) .
Sequential immunoprecipitations were done by pretreating radiolabeled extracts overnight with either excess normal mouse serum or antiserum, After removal of immune complexes with Staphylococcus aureus, the extracts were divided and subjected to second immunoprecipitations overnight with various test antisera. The antigen-antibody complexes were removed with 5: aureus, and the Ia molecules were anlayzed by SDS gel electrophoresis.
Results and Discussion
Serological Identification. initial cytotoxic studies carried out with fresh spleen cells from Fa animals showed only weak reactions• All the cytotoxic tests reported in this manuscript was done with LPS-stimulated spleen blasts to enrich for B lymphocytes as well as to enhance lysis. Viable blast cells from 48-to 72-h cultures were separated from dead cells by layering on Ficoll-Isopaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.). As shown in Fig. 1 , LPS spleen blasts from (B10 × B10.D2)F1, B10, and B10.D2 were tested with anti-22 sera. The antiserum (C3H.Q × B10.D2)F1 anti-B10.AQR killed -50-60% of the F1 LPS blasts up to a titer of 1 in 160, whereas no lysis was obtained with the two parental cells. All three targets were uniformly lysed by anti-Ia.8 (I-A). These results indicated that Ia.22 is expressed on the hybrid molecules generated by the complementation of A b with E a. Several more F1 combinations and antisera were tested to confirm this observation (Table II) As shown in Fig. 2 , both D2.GD and B10.A(5R) LPS spleen blasts are negative for Ia.23. Yet, the F1 LPS spleen blasts from [D2.GD × B10.A(5R)] gave strong positive reactions. Hence, Ia.23 can be generated by the complementation of Ad with E k.
Again, identical expression of Ia.8 (I-A) was seen in all three targets. As shown in In an attempt to test whether the anti-Ia.22 and anti-Ia.23 sera were detecting the same hybrid Ia determinant in the independent haplotype (homologous ciscomplementation), recombinant (nonhomologous ciscomplementation), and in the F] hybrids (transcomplementation), cross-absorptions were done. Anti-Ia.22 was absorbed with B10.K, B10.A(3R), and (B10 × B10.D2)FI LPS spleen blasts and then tested with LPS spleen blasts from these strains as targets. Each cell type completely absorbed for each other. Similarly, B 10.D2 and [D2.GD X B 10.A(5R)]F1 cells were used to absorb anti-Ia.23 and tested against both the cell types. Again, complete absorption was seen. These results suggest that the antisera were detecting the same determinant in all three types of complementation. Gel fraction (2mm) 
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